Sally E Dodds1, Thaddeus W W Pace2, Melanie L Bell3, Mallorie Fiero3, Lobsang Tenzin Negi4, Charles L Raison5, Karen L Weihs5. 1. University of Arizona College of Medicine, Tucson, AZ, 85724, USA. sdodds1@email.arizona.edu. 2. University of Arizona College of Nursing, Tucson, AZ, 85721, USA. 3. University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, 85724, USA. 4. Emory University, Atlanta, GA, 30322, USA. 5. University of Arizona College of Medicine, Tucson, AZ, 85724, USA.
Abstract
PURPOSE: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. METHODS:Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a "booster" CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. RESULTS:Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. CONCLUSIONS: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. RELEVANCE: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.
RCT Entities:
PURPOSE: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. METHODS:Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a "booster" CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. RESULTS: Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. CONCLUSIONS: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. RELEVANCE: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.
Entities:
Keywords:
Breast cancer; Compassion; Depression; Fear of cancer recurrence; Meditation; Stress; Survivorship
Authors: Mogens Groenvold; Morten Aagaard Petersen; Ellen Idler; Jakob Bue Bjorner; Peter M Fayers; Henning T Mouridsen Journal: Breast Cancer Res Treat Date: 2007-01-03 Impact factor: 4.872
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Julienne E Bower; Patricia A Ganz; Michael R Irwin; Lorna Kwan; Elizabeth C Breen; Steve W Cole Journal: J Clin Oncol Date: 2011-08-08 Impact factor: 44.544
Authors: Linda E Carlson; Richard Doll; Joanne Stephen; Peter Faris; Rie Tamagawa; Elaine Drysdale; Michael Speca Journal: J Clin Oncol Date: 2013-08-05 Impact factor: 44.544
Authors: Danielle Petricone-Westwood; Georden Jones; Brittany Mutsaers; Caroline Séguin Leclair; Christina Tomei; Geneviève Trudel; Andreas Dinkel; Sophie Lebel Journal: Int J Behav Med Date: 2019-02
Authors: Ronna N Robbins; Jessica L Kelleher; Priyathama Vellanki; Jason C O'Connor; Jennifer S Mascaro; Joe R Nocera; Monica C Serra Journal: J Funct Morphol Kinesiol Date: 2022-06-01
Authors: Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy Journal: CA Cancer J Clin Date: 2017-04-24 Impact factor: 508.702
Authors: Amy K Otto; Elana C Szczesny; Emily C Soriano; Jean-Philippe Laurenceau; Scott D Siegel Journal: Health Psychol Date: 2016-08-11 Impact factor: 4.267
Authors: Daniel L Hall; Christina M Luberto; Lisa L Philpotts; Rhayun Song; Elyse R Park; Gloria Y Yeh Journal: Psychooncology Date: 2018-06-05 Impact factor: 3.894
Authors: Ellen Krueger; Ekin Secinti; Catherine E Mosher; Patrick V Stutz; Andrea A Cohee; Shelley A Johns Journal: Cancer Nurs Date: 2021 Nov-Dec 01 Impact factor: 2.592
Authors: Angela Mifsud; Melissa J Pehlivan; Paul Fam; Maddison O'Grady; Annamiek van Steensel; Elisabeth Elder; Jenny Gilchrist; Kerry A Sherman Journal: Health Psychol Behav Med Date: 2021-05-21
Authors: Jennifer S Mascaro; Marianne P Florian; Marcia J Ash; Patricia K Palmer; Anuja Sharma; Deanna M Kaplan; Roman Palitsky; George Grant; Charles L Raison Journal: Front Psychol Date: 2022-04-05
Authors: Shelley A Johns; Will L Tarver; Ekin Secinti; Catherine E Mosher; Patrick V Stutz; Jennifer L Carnahan; Tasneem L Talib; Mackenzie L Shanahan; Micah T Faidley; Kelley M Kidwell; Kevin L Rand Journal: Crit Rev Oncol Hematol Date: 2021-03-04 Impact factor: 6.312
Authors: Andrea Salvador Zaragozá; Ana Soto-Rubio; Laura Lacomba-Trejo; Selene Valero-Moreno; Marian Pérez-Marín Journal: Curr Psychol Date: 2021-06-25